First in New Class of Drugs in More than a Decade for SLE and Targeting Type 1 Interferons NEW YORK, Aug. 2, 2021 /PRNewswire/ -- The Lupus Research Alliance (LRA) is particularly excited about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback